-
Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and
-
Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more
-
Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and
-
Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and
-
pioneering research and innovation hub in AI—one that will shape the way humans and machines collaborate for decades to come. Led by Prof. Usama Fayyad, the Institute for Experiential AI is built around the
-
based upon funding and performance. This position will be based in the Social Development and Wellbeing Lab led by Dr. Alexandra Rodman. The Lab and offices are the heart of Boston, in the new, state
-
, there may be opportunities to contribute to projects within other functional areas, e.g., clinical development, pharmacovigilance, etc. and/or other projects that are being led by other BBIO affiliates